News: Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

30.61USD
2:17pm EDT
Price Change (% chg)

$0.45 (+1.49%)
Prev Close
$30.16
Open
$30.01
Day's High
$30.73
Day's Low
$29.91
Volume
406,906
Avg. Vol
1,699,440
52-wk High
$35.40
52-wk Low
$28.97

Search Stocks
Select another date:

Mon, Jun 24 2013

Photo

Pfizer says shareholders snap up remaining Zoetis shares

- Pfizer Inc on Monday said it would complete the spinoff of its Zoetis Inc animal health business after investors offered to trade their Pfizer shares for the company's remaining majority stake in the unit.

UPDATE 2-Pfizer says shareholders snap up remaining Zoetis shares

June 24 - Pfizer Inc on Monday said it would complete the spinoff of its Zoetis Inc animal health business after investors offered to trade their Pfizer shares for the company's remaining majority stake in the unit.

Pfizer says shareholders snap up remaining Zoetis shares

June 24 - Pfizer Inc said on Monday that enough Pfizer shareholders offered to trade their shares for stock in Pfizer's majority owned Zoetis Inc animal health business to allow Pfizer to complete its spinoff of the unit.

Pfizer to spin off Zoetis stake to shareholders

- Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount.

UPDATE 2-Pfizer to spin off Zoetis stake to shareholders

May 22 - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount.

BRIEF-Pfizer up in premarket after plans to unwind remaining majority stake in Zoetis

NEW YORK, May 22 - Pfizer Inc : * Up 2.2 percent to $29.40 in premarket after plans to unwind remaining majority stake in Zoetis

Strong pet product sales help Zoetis top estimates

- Zoetis Inc , formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer Inc , posted a stronger-than-expected quarterly profit, driven by growth in sales of pet products in the United States.

UPDATE 2-Strong pet product sales help Zoetis top estimates

April 30 - Zoetis Inc, formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer Inc , posted a stronger-than-expected quarterly profit, driven by growth in sales of pet products in the United States.

Zoetis profit beats Street on strong pet product sales

- Zoetis Inc , formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer Inc , posted a better-than-expected quarterly profit, driven by strong growth in sales of pet products in the United States.

Zoetis profit beats Street on strong pet product sales

April 30 - Zoetis Inc, formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer Inc , posted a better-than-expected quarterly profit, driven by strong growth in sales of pet products in the United States.

Select another date:
Search Stocks